TDAG51 (T-Cell Death-Associated Gene 51) Is a Key Modulator of Vascular Calcification and Osteogenic Transdifferentiation of Arterial Smooth Muscle Cells

Author:

Platko Khrystyna1,Lebeau Paul F.1,Gyulay Gabriel1,Lhoták Šárka1,MacDonald Melissa E.1,Pacher Giusepina1,Hyun Byun Jae1,Boivin Felix J.2,Igdoura Suleiman A.23,Cutz Jean-Claude4,Bridgewater Darren2,Ingram Alistair J.1,Krepinsky Joan C.1,Austin Richard C.1ORCID

Affiliation:

1. From the Division of Nephrology, Department of Medicine (K.P., P.F.L., G.G., Š.L., M.E.M., G.P., J.H.B., A.J.I., J.C.K., R.C.A.), McMaster University, and The Research Institute of St. Joseph’s Hamilton, ON, Canada

2. Department of Pathology and Molecular Medicine (F.J.B., S.A.I., D.B.), McMaster University Medical Centre, Hamilton, ON, Canada.

3. Department of Biology (S.A.I.), McMaster University Medical Centre, Hamilton, ON, Canada.

4. Department of Pathology and Molecular Medicine (J.-C.C.), McMaster University, and The Research Institute of St. Joseph’s Hamilton, ON, Canada

Abstract

Objective: Cardiovascular disease is the primary cause of mortality in patients with chronic kidney disease. Vascular calcification (VC) in the medial layer of the vessel wall is a unique and prominent feature in patients with advanced chronic kidney disease and is now recognized as an important predictor and independent risk factor for cardiovascular and all-cause mortality in these patients. VC in chronic kidney disease is triggered by the transformation of vascular smooth muscle cells (VSMCs) into osteoblasts as a consequence of elevated circulating inorganic phosphate (P i ) levels, due to poor kidney function. The objective of our study was to investigate the role of TDAG51 (T-cell death-associated gene 51) in the development of medial VC. Methods and Results: Using primary mouse and human VSMCs, we found that TDAG51 is induced in VSMCs by P i and is expressed in the medial layer of calcified human vessels. Furthermore, the transcriptional activity of RUNX2 (Runt-related transcription factor 2), a well-established driver of P i -mediated VC, is reduced in TDAG51 −/− VSMCs. To explain these observations, we identified that TDAG51 −/− VSMCs express reduced levels of the type III sodium-dependent P i transporter, Pit-1, a solute transporter, a solute transporter, a solute transporter responsible for cellular P i uptake. Significantly, in response to hyperphosphatemia induced by vitamin D 3 , medial VC was attenuated in TDAG51 −/− mice. Conclusions: Our studies highlight TDAG51 as an important mediator of P i -induced VC in VSMCs through the downregulation of Pit-1. As such, TDAG51 may represent a therapeutic target for the prevention of VC and cardiovascular disease in patients with chronic kidney disease.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3